https://www.apollohealthco.com/wp-content/uploads/2019/08/Apollo-Health-Share-686x360.jpg

August 22, 2019Alzheimer’s, Press Releases

Reversal of Cognitive Decline: 100 Patients

https://www.apollohealthco.com/wp-content/uploads/2019/11/Apollo-Health-Share-2-686x360.jpg

March 4, 2019Alzheimer’s, Industry News, Nutrition, Press Releases

LifeSeasons and Dr. Dale Bredesen Announce New Products to Support the Treatment of Alzheimer’s Disease and Cognitive Decline

https://www.apollohealthco.com/wp-content/uploads/2019/08/Apollo-Health-Share-686x360.jpg

July 26, 2018Alzheimer’s, Press Releases

AHNP Precision Health Launches the ReCODE Report

Partnering with Dr. Dale Bredesen, Alzheimer’s research pioneer and inventor of The Bredesen Protocol, AHNP Precision Health has launched the US version of the ReCODE Report, a proprietary implementation of the Bredesen Protocol which allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Read More »

https://www.apollohealthco.com/wp-content/uploads/2019/08/Apollo-Health-Share-686x360.jpg

July 6, 2018Alzheimer’s, Press Releases

AHNP Precision Health Acquires MPI Cognition Dementia Business

AHNP Precision Health is announcing its acquisition of the MPI Cognition dementia business in order to rapidly bring a ground-breaking Alzheimer’s treatment protocol designed by the leading Alzheimer’s researcher to the market. Dale Bredesen MD, Founder, Co-Chairman, and Chief Science Officer of MPI Cognition is the best-selling author of the highly-acclaimed book, The End of Alzheimer’s. Read More »